Detalhe da pesquisa
1.
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia.
Cancer
; 128(15): 2922-2931, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612815
2.
Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
Biol Blood Marrow Transplant
; 21(12): 2091-2099, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26253007
3.
Janus kinase inhibitors and allogeneic stem cell transplantation for myelofibrosis.
Biol Blood Marrow Transplant
; 20(9): 1274-81, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24680977
4.
Micafungin as antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: results of different dosage levels in clinical practice.
Clin Transplant
; 28(3): 286-91, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24479680
5.
Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of life.
Mult Scler Relat Disord
; 82: 105414, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38176284
6.
Iron Chelation with Deferasirox Suppresses the Appearance of Labile Plasma Iron During Conditioning Chemotherapy Prior to Allogeneic Stem Cell Transplantation.
Transplant Cell Ther
; 29(1): 42.e1-42.e6, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36241148
7.
Iron Chelation With Deferasirox Increases Busulfan AUC During Conditioning Chemotherapy Prior to Allogeneic Stem Cell Transplantation.
Transplant Cell Ther
; 28(2): 115.e1-115.e5, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34775147
8.
Chimeric antigen receptor T-cell therapy and fludarabine: precision dosing imperatives.
Blood Adv
; 8(3): 797-798, 2024 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191740